eISSN: 3023-3267 editor@aimjournals.com
All Journals
Submit your article

Critique Open Research & Review

Open Access Peer Review International
Open Access

A NOVEL PRECIPITATION METHOD FOR SOLIDIFYING THERAPEUTIC MONOCLONAL ANTIBODIES: A COST-EFFECTIVE ALTERNATIVE TO LYOPHILIZATION

DOI https://doi.org/10.55640/corr-v03i02-01
PDF
Jane A. Doe 1 ,
4 Department of Biochemistry, Global Health Research Institute, Boston, USA

Abstract

Therapeutic monoclonal antibodies (mAbs) have become integral in the treatment of various diseases, but their formulation and stability remain challenges for long-term storage and distribution. Traditionally, lyophilization (freeze-drying) is employed to convert mAbs into solid formulations; however, this process is time-consuming, costly, and can lead to protein instability. In contrast, a precipitation-based process offers a potential alternative for generating solid mAb formulations. This study explores the use of ammonium sulfate as a precipitating agent to solidify monoclonal antibodies while maintaining their bioactivity and stability. The process involved optimizing precipitation conditions, followed by characterizing the precipitated product using size exclusion chromatography (SEC), dynamic light scattering (DLS), and circular dichroism (CD) spectroscopy. Results demonstrated that the precipitation method achieved high yields (over 85%), with minimal aggregation and preserved structural integrity of the mAb. The solid formulation showed excellent reconstitution properties, and bioactivity assays confirmed that the mAb retained its therapeutic function. Additionally, the precipitated mAb exhibited long-term stability at room temperature, making this precipitation-based method a promising alternative to lyophilization for mAb formulation. This approach is cost-effective, scalable, and provides an efficient solution for producing stable monoclonal antibody therapies.

Keywords

Monoclonal Antibodies, Precipitation, Solid Formulation

References

Senior, M. Fresh from the biotech pipeline: Fewer approvals, but biologics gain share. Nat. Biotechnol. 2023, 41, 174–182. [Google Scholar] [CrossRef] [PubMed]
Chen, Y.; Mutukuri, T.T.; Wilson, N.E.; Zhou, Q. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability. Adv. Drug Deliv. Rev. 2021, 172, 211–233. [Google Scholar] [CrossRef] [PubMed]
Sharma, A.; Khamar, D.; Cullen, S.; Hayden, A.; Hughes, H. Innovative Drying Technologies for Biopharmaceuticals. Int. J. Pharm. 2021, 609, 121115. [Google Scholar] [CrossRef] [PubMed]
Stratta, L.; Capozzi, L.C.; Franzino, S.; Pisano, R. Economic Analysis of a Freeze-Drying Cycle. Processes 2020, 8, 1399. [Google Scholar] [CrossRef]
Heller, M.C.; Carpenter, J.F.; Randolph, T.W. Protein formulation and lyophilization cycle design: Prevention of damage due to freeze-concentration induced phase separation. Biotechnol. Bioeng. 1999, 63, 166–174. [Google Scholar] [CrossRef]
Kasper, J.C.; Friess, W. The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur. J. Pharm. Biopharm. 2011, 78, 248–263. [Google Scholar] [CrossRef]
Patel, S.M.; Nail, S.L.; Pikal, M.J.; Geidobler, R.; Winter, G.; Hawe, A.; Davagnino, J.; Rambhatla Gupta, S. Lyophilized Drug Product Cake Appearance: What Is Acceptable? J. Pharm. Sci. 2017, 106, 1706–1721. [Google Scholar] [CrossRef]
Jameel, F.; Alexeenko, A.; Bhambhani, A.; Sacha, G.; Zhu, T.; Tchessalov, S.; Sharma, P.; Moussa, E.; Iyer, L.; Luthra, S.; et al. Recommended Best Practices for Lyophilization Validation 2021 Part II: Process Qualification and Continued Process Verification. AAPS PharmSciTech 2021, 22, 266. [Google Scholar] [CrossRef]
Searles, J.; Ohtake, S. Strategies for Implementing New Drying & Packaging Technology for Sterile Injectable Drug Products. J. Pharm. Sci. 2021, 110, 1931–1934. [Google Scholar]
Ohtake, S.; Izutsu, K.; Lechuga-Ballesteros, D. Drying Technologies for Biotechnology and Pharmaceutical Applications; Wiley: New York, NY, USA, 2020. [Google Scholar]
Barcelo-Chong, C.M.; Filipe, V.; Nakach, M.; Inês Ré, M. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect. Int. J. Pharm. 2024, 655, 124014. [Google Scholar] [CrossRef]
Pinto, J.T.; Faulhammer, E.; Dieplinger, J.; Dekner, M.; Makert, C.; Nieder, M.; Paudel, A. Progress in spray-drying of protein pharmaceuticals: Literature analysis of trends in formulation and process attributes. Dry. Technol. 2021, 39, 1415–1446. [Google Scholar] [CrossRef]
Tao, Y.; Chen, Y.; Howard, W.; Ibrahim, M.; Patel, S.M.; McMahon, W.P.; Kim, Y.J.; Delmar, J.A.; Davis, D. Mechanism of Insoluble Aggregate Formation in a Reconstituted Solution of Spray-Dried Protein Powder. Pharm. Res. 2023, 40, 2355–2370. [Google Scholar] [CrossRef] [PubMed]
Anandharamakrishnan, C.; Rielly, C.D.; Stapley, A.G.F. Loss of solubility of α-lactalbumin and β-lactoglobulin during the spray drying of whey proteins. LWT—Food Sci. Technol. 2008, 41, 270–277. [Google Scholar] [CrossRef]
Forbes, R.T.; Barry, B.W.; Elkordy, A.A. Preparation and characterisation of spray-dried and crystallised trypsin: FT-Raman study to detect protein denaturation after thermal stress. Eur. J. Pharm. Sci. 2007, 30, 315–323. [Google Scholar] [CrossRef]
Poozesh, S.; Mezhericher, M.; Pan, Z.; Chaudhary, U.; Manikwar, P.; Stone, H.A. Rapid Room-Temperature Aerosol Dehydration Versus Spray Drying: A Novel Paradigm in Biopharmaceutical Drying Technologies. J. Pharm. Sci. 2024, 113, 974–981. [Google Scholar] [CrossRef]
Adler, M.; Unger, M.; Lee, G. Surface Composition of Spray-Dried Particles of Bovine Serum Albumin/Trehalose/Surfactant. Pharm. Res. 2000, 17, 863–870. [Google Scholar] [CrossRef]
Hickey, A.J.; da Rocha, S.R. Pharmaceutical Inhalation Aerosol Technology; Hickey, A.J., da Rocha, S.R., Eds.; CRC Press: Boca Raton, FL, USA, 2019. [Google Scholar]
Abdul-Fattah, A.M.; Kalonia, D.S.; Pikal, M.J. The Challenge of Drying Method Selection for Protein Pharmaceuticals: Product Quality Implications. J. Pharm. Sci. 2007, 96, 1886–1916. [Google Scholar] [CrossRef]
Chang, R.Y.K.; Chow, M.Y.T.; Khanal, D.; Chen, D.; Chan, H.-K. Dry powder pharmaceutical biologics for inhalation therapy. Adv. Drug Deliv. Rev. 2021, 172, 64–79. [Google Scholar] [CrossRef]
Pan, H.W.; Seow, H.C.; Lo, J.C.K.; Guo, J.; Zhu, L.; Leung, S.W.S.; Zhang, C.; Lam, J.K.W. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery. Pharm. Res. 2022, 39, 2291–2304. [Google Scholar] [CrossRef]
Bhambhani, A.; Stanbro, J.; Roth, D.; Sullivan, E.; Jones, M.; Evans, R.; Blue, J. Evaluation of Microwave Vacuum Drying as an Alternative to Freeze-Drying of Biologics and Vaccines: The Power of Simple Modeling to Identify a Mechanism for Faster Drying Times Achieved with Microwave. AAPS PharmSciTech 2021, 22, 52. [Google Scholar] [CrossRef]
Ambros, S.; Dombrowski, J.; Boettger, D.; Kulozik, U. The Concept of Microwave Foam Drying Under Vacuum: A Gentle Preservation Method for Sensitive Biological Material. J. Food Sci. 2019, 84, 1682–1691. [Google Scholar] [CrossRef] [PubMed]
Lovalenti, P.M.; Anderl, J.; Yee, L.; Nguyen, V.; Ghavami, B.; Ohtake, S.; Saxena, A.; Voss, T.; Truong-Le, V. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying. Pharm. Res. 2016, 33, 1144–1160. [Google Scholar] [CrossRef] [PubMed]
Piettre, M.; Vila, A. Sur la separation des proteines du serum. Comptes Rendus Hebd. Seances Acad. Sci 1920, 170, 1466–1468. [Google Scholar]
Barritault, D.; Expert-Bezançon, A.; Guérin, M.-F.; Hayes, D. The Use of Acetone Precipitation in the Isolation of Ribosomal Proteins. Eur. J. Biochem. 1976, 63, 131–135. [Google Scholar] [CrossRef]
Crowell, A.M.J.; Wall, M.J.; Doucette, A.A. Maximizing recovery of water-soluble proteins through acetone precipitation. Anal. Chim. Acta 2013, 796, 48–54. [Google Scholar] [CrossRef]
Jiang, L.; He, L.; Fountoulakis, M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis. J. Chromatogr. A 2004, 1023, 317–320. [Google Scholar] [CrossRef]
Aniket; Gaul, D.A.; Rickard, D.L.; Needham, D. MicroglassificationTM: A Novel Technique for Protein Dehydration. J. Pharm. Sci. 2014, 103, 810–820. [Google Scholar] [CrossRef]
Aniket; Gaul, D.A.; Bitterfield, D.L.; Su, J.T.; Li, V.M.; Singh, I.; Morton, J.; Needham, D. Enzyme Dehydration Using Microglassification™ Preserves the Protein’s Structure and Function. J. Pharm. Sci. 2015, 104, 640–651. [Google Scholar] [CrossRef]
Chandrababu, K.B.; Kannan, A.; Savage, J.R.; Stadmiller, S.; Ryle, A.E.; Cheung, C.; Kelley, R.F.; Maa, Y.-f.; Saggu, M.; Bitterfield, D.L. Stability Comparison Between Microglassification and Lyophilization Using a Monoclonal Antibody. J. Pharm. Sci. 2023, 113, 1054–1060. [Google Scholar] [CrossRef]
Yoshikawa, H.; Hirano, A.; Arakawa, T.; Shiraki, K. Mechanistic insights into protein precipitation by alcohol. Int. J. Biol. Macromol. 2012, 50, 865–871. [Google Scholar] [CrossRef]
Cohn, E.J.; Strong, L.E.; Hughes, W.L.J.; Mulford, D.J.; Ashworth, J.N.; Melin, M.E.; Taylor, H.L. Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 1946, 68, 459–475. [Google Scholar] [CrossRef] [PubMed]
Somasundaram, B.; Pleitt, K.; Shave, E.; Baker, K.; Lua, L.H.L. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges. Biotechnol. Bioeng. 2018, 115, 2893–2907. [Google Scholar] [CrossRef] [PubMed]
Li, Z.; Chen, T.-H.; Andini, E.; Coffman, J.L.; Przybycien, T.; Zydney, A.L. Enhanced filtration performance using feed-and-bleed configuration for purification of antibody precipitates. Biotechnol. Prog. 2021, 37, e3082. [Google Scholar] [CrossRef] [PubMed]

Most read articles by the same author(s)

<< < 1 2 3 4 5 6